5 completed, 1 terminated, 1 unknown. 7 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 5, Terminated 1, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow Paliperidone: new trials by email Literature Review of Paliperidone trials Research Report on Paliperidone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Substance Misuse To Psychosis for Stimulants Aripiprazole, Paliperidone, Treatment as Usual - Stimulant Use With Stimulant-Induced Psychotic Disorder (Diagnosis), Schizophrenia and Related Disorders | Phase 2 / Phase 3 | Completed | The University of Hong Kong | 165 | 2019-06-01 | 2026-03-27 |
| Pharmacovigilance in Gerontopsychiatric Patients Phenobarbital, Phenytoin, Carbamazepine - Dementia, Depression | Phase 3 | Terminated | Hannover Medical School | 407 | 2015-01-01 | 2018-02-28 |
| Clinical Trial to Evaluate the Efficacy of Treatment vs Discontinuation in a First Episode of Non-affective Psychosis Discontinuation antipsychotic treatment, Antipsychotic treatment - Psychosis Nos/Other | Phase 3 | Unknown | Fundación Pública Andaluza Progreso y Salud | 104 | 2012-11-01 | 2014-12-05 |
| An Efficacy Study of Paliperidone for the Prevention of Relapse in Participants With Schizophrenia Paliperidone, Placebo - Schizophrenia | Phase 3 | Completed | Janssen Research & Development, LLC | 201 | 2011-06-01 | 2014-09-29 |
| An Efficacy and Safety Study of Paliperidone Extended-Release (ER) Tablets in Participants With Schizophrenia Paliperidone - Schizophrenia | Phase 3 | Completed | Janssen-Cilag International NV | 294 | 2007-07-01 | 2013-08-02 |
| An Open Label Multicentre Study to Determine the Dose Distribution of Paliperidone ER in Patients With Schizophrenia Paliperidone - Schizophrenia | Phase 3 | Completed | Janssen-Cilag Pty Ltd | 64 | 2007-04-01 | 2012-12-05 |
| A 52 Week Open-label Extension Trial Following the Double-blind Efficacy and Safety Study R076477-SCH-305. Paliperidone - Schizophrenia | Phase 3 | Completed | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 407 | 2004-02-01 | 2011-06-08 |
Schizophrenia (6) · Anxiety Disorders (1) · Dementia (1) · Depression (1) · Disease (1) · Psychophysiologic Disorders (1) · Psychotic Disorders (1)
Fundación Pública Andaluza Progreso y Salud (1) · Hannover Medical School (1) · Janssen Research & Development, LLC (1) · Janssen-Cilag International NV (1) · Janssen-Cilag Pty Ltd (1) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (1) · The University of Hong Kong (1)
Germany (2) · China (1) · Croatia (1) · France (1) · Hong Kong (1) · Israel (1) · Lithuania (1) · Poland (1) · Romania (1) · Spain (1)
Helge Frieling, Prof., MD (1) · Miguel Ruiz Veguilla, MD, PhD (1)